Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Tenivac Generic Name & Formulations
Legal Class
Rx
General Description
Tetanus and diphtheria toxoids; aluminum adsorbed; susp for IM inj; preservative-free.
Pharmacological Class
Td vaccine.
How Supplied
Single-dose vials (0.5mL)—10
Single-dose prefilled syringe (0.5mL)—10
Single-dose prefilled syringe (0.5mL)—10
Manufacturer
Tenivac Indications
Indications
Tetanus and diphtheria immunization in patients >7yrs.
Tenivac Dosage and Administration
Adults and Children
<7yrs: not established. >7yrs: Give IM in deltoid muscle. Previously unvaccinated: three 0.5mL doses, administer first two doses 2 months apart and then third dose 6–8 months after second dose. Routine booster: give at 11–12yrs of age and every 10 years thereafter. Diphtheria and tetanus prophylaxis: see full labeling.
Tenivac Contraindications
Contraindications
Anaphylaxis associated with a previous dose.
Tenivac Boxed Warnings
Not Applicable
Tenivac Warnings/Precautions
Warnings/Precautions
Guillain-Barre syndrome within 6 weeks of previous tetanus toxoid vaccine. Previous Arthus-type hypersensitivity reaction: not recommended until ≥10yrs after prior dose of tetanus toxoid-containing vaccine. Immunodeficiency. Have epinephrine (1:1000) available. Latex allergy (syringe tip cap). Pregnancy (Cat.C). Nursing mothers.
Tenivac Pharmacokinetics
See Literature
Tenivac Interactions
Interactions
Concomitant tetanus immune globulin (human): inject at separate site with separate needle and syringe if passive protection required. Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may get suboptimal response.
Tenivac Adverse Reactions
Adverse Reactions
Injection site reactions (eg, pain, redness, swelling), headache, malaise, muscle weakness, joint pain.
Tenivac Clinical Trials
See Literature
Tenivac Note
Not Applicable
Tenivac Patient Counseling
See Literature
